33110096|t|Structural modeling of GSK3beta implicates the inactive (DFG-out) conformation as the target bound by TDZD analogs.
33110096|a|Glycogen synthase kinase-3beta (GSK3beta) controls many physiological pathways, and is implicated in many diseases including Alzheimer's and several cancers. GSK3beta-mediated phosphorylation of target residues in microtubule-associated protein tau (MAPTAU) contributes to MAPTAU hyperphosphorylation and subsequent formation of neurofibrillary tangles. Inhibitors of GSK3beta protect against Alzheimer's disease and are therapeutic for several cancers. A thiadiazolidinone drug, TDZD-8, is a non-ATP-competitive inhibitor targeting GSK3beta with demonstrated efficacy against multiple diseases. However, no experimental data or models define the binding mode of TDZD-8 with GSK3beta, which chiefly reflects our lack of an established inactive conformation for this protein. Here, we used metadynamic simulation to predict the three-dimensional structure of the inactive conformation of GSK3beta. Our model predicts that phosphorylation of GSK3beta Serine9 would hasten the DFG-flip to an inactive state. Molecular docking and simulation predict the TDZD-8 binding conformation of GSK3beta to be inactive, and are consistent with biochemical evidence for the TDZD-8-interacting residues of GSK3beta. We also identified the pharmacophore and assessed binding efficacy of second-generation TDZD analogs (TDZD-10 and Tideglusib) that bind GSK3beta as non-ATP-competitive inhibitors. Based on these results, the predicted inactive conformation of GSK3beta can facilitate the identification of novel GSK3beta inhibitors of high potency and specificity.
33110096	23	31	GSK3beta	Gene	2932
33110096	57	60	DFG	Chemical	-
33110096	102	106	TDZD	Chemical	-
33110096	116	146	Glycogen synthase kinase-3beta	Gene	2932
33110096	148	156	GSK3beta	Gene	2932
33110096	241	252	Alzheimer's	Disease	MESH:D000544
33110096	265	272	cancers	Disease	MESH:D009369
33110096	274	282	GSK3beta	Gene	2932
33110096	330	364	microtubule-associated protein tau	Gene	4137
33110096	366	372	MAPTAU	Gene	4137
33110096	389	395	MAPTAU	Gene	4137
33110096	445	468	neurofibrillary tangles	Disease	MESH:D055956
33110096	484	492	GSK3beta	Gene	2932
33110096	509	528	Alzheimer's disease	Disease	MESH:D000544
33110096	561	568	cancers	Disease	MESH:D009369
33110096	572	589	thiadiazolidinone	Chemical	-
33110096	596	602	TDZD-8	Chemical	MESH:C494356
33110096	613	616	ATP	Chemical	MESH:D000255
33110096	649	657	GSK3beta	Gene	2932
33110096	779	785	TDZD-8	Chemical	MESH:C494356
33110096	791	799	GSK3beta	Gene	2932
33110096	1003	1011	GSK3beta	Gene	2932
33110096	1056	1064	GSK3beta	Gene	2932
33110096	1090	1093	DFG	Chemical	-
33110096	1166	1172	TDZD-8	Chemical	MESH:C494356
33110096	1197	1205	GSK3beta	Gene	2932
33110096	1275	1281	TDZD-8	Chemical	MESH:C494356
33110096	1306	1314	GSK3beta	Gene	2932
33110096	1404	1408	TDZD	Chemical	-
33110096	1418	1425	TDZD-10	Chemical	-
33110096	1430	1440	Tideglusib	Chemical	MESH:C520571
33110096	1452	1460	GSK3beta	Gene	2932
33110096	1468	1471	ATP	Chemical	MESH:D000255
33110096	1559	1567	GSK3beta	Gene	2932
33110096	1611	1619	GSK3beta	Gene	2932
33110096	Negative_Correlation	MESH:C494356	2932
33110096	Association	MESH:D055956	2932
33110096	Negative_Correlation	MESH:C520571	MESH:D000255
33110096	Association	MESH:D000544	2932
33110096	Association	2932	4137
33110096	Association	MESH:D055956	4137
33110096	Negative_Correlation	MESH:C520571	2932
33110096	Association	MESH:D009369	2932

